To buy shares in Regencell Bioscience Holdings Limited you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $16.58 to buy one share in Regencell Bioscience Holdings Limited (as of 11:29 29-Oct-2025). Which is a change of $0.7 or -4.05% from the last closing price of $17.28.
How To Buy Regencell Bioscience Holdings Limited Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Regencell Bioscience Holdings Limited:
- Pick a stock broker (jump down to compare the best brokers for buying Regencell Bioscience Holdings Limited stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:RGC)
- Choose the number of shares you want to buy (1 share currently costs $16.58)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Regencell Bioscience Holdings Limited stock in your account (this will show your profit and loss)
- Regencell Bioscience Holdings Limited is currently worth $8,322,248,149 based on the last closing price of $17.28 with 43,477 shares traded.
- The most recent Regencell Bioscience Holdings Limited daily high has been $17.25 and daily low $16.5.
- The Regencell Bioscience Holdings Limited stock price 52 week high has been $83.6 and the 52 week low $0.09.
Compare Brokers For Buying Regencell Bioscience Holdings Limited Stock
Is Now A Good Time To Buy Regencell Bioscience Holdings Limited Stock?
- Regencell Bioscience Holdings Limited’s EPS (earnings per share) are 0.01. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Regencell Bioscience Holdings Limited’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Regencell Bioscience Holdings Limited share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.